Vext Science Expands Ohio Footprint with New Fairfield Dispensary

The latest update is out from Vext Science ( (TSE:VEXT) ).

Vext Science, Inc. has secured a provisional license for its sixth cannabis dispensary in Fairfield, Ohio, with operations expected to commence in the fourth quarter of 2025, subject to regulatory approvals. This strategic expansion highlights Vext’s disciplined approach to growth, leveraging high-traffic locations and limited competition to drive cash flow and shareholder value. The new Fairfield location, adjacent to Jungle Jim’s International Market, is expected to enhance visibility and consumer traffic, further solidifying Vext’s market position in Ohio as it approaches the state’s dispensary license cap of eight.

The most recent analyst rating on (TSE:VEXT) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Vext Science stock, see the TSE:VEXT Stock Forecast page.

Spark’s Take on TSE:VEXT Stock

According to Spark, TipRanks’ AI Analyst, TSE:VEXT is a Neutral.

Vext Science’s overall stock score is driven by financial performance challenges, particularly in profitability and cash flow. However, the positive momentum from recent earnings, driven by revenue growth and strategic expansion, provides a counterbalance. The technical analysis and valuation raise additional concerns.

To see Spark’s full report on TSE:VEXT stock, click here.

More about Vext Science

Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. The company focuses on the cultivation, manufacturing, and retail of cannabis products, serving both medical and adult-use markets. Vext is strategically expanding its presence in Ohio, aiming to capitalize on the state’s cannabis market potential.

Average Trading Volume: 150,627

Technical Sentiment Signal: Sell

Current Market Cap: C$33.42M

For an in-depth examination of VEXT stock, go to TipRanks’ Overview page.